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Abstract
We recently demonstrated that citrulline (CIT) reduced the expression of inflammatory genes in cultured explants from retroperitoneal
(RET) white adipose tissue (WAT) from young (2–4 months) but not old (25 months) rats. Here we show that in RET WAT from old rats and
high-fat-diet-fed (HFD) young rats, the basal expression of the leptin gene was increased (275–345%) whereas that of the adiponectin gene
was decreased (48–60%), when compared to those from control-diet-fed (CD) young rats. We show also that in RET WAT from old rats,
a diet supplemented with CIT for 3 months reduced macrophage (F4/80, CD68) and inflammation (interleukin-6, tumor necrosis factor-α)
marker genes 23–97%. CIT supplementation lowered leptin mRNA 62% and increased adiponectin mRNA 232%. In cultured explants of
RET WAT from 4 month-old CD, 4 month-old HFD and 25-month-old CD rats, the exposure to 2.5 mmol/L CIT for 24 h up-regulated
adiponectin gene expression 151%, 362% and 216% respectively. In contrast, leptin gene expression was down-regulated 66% selectively
in CIT-treated explants from 25-month-old CD rats. These results further support the proposed beneficial effect of CIT to counteract the
deleterious effects of aging and overweight on the metabolic, inflammatory and endocrine functions of WAT.
© 2015 The Authors. Published by Elsevier B.V. on behalf of Société Française de Biochimie et Biologie Moléculaire (SFBBM).
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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a. Introduction
Citrulline (CIT) has interesting nutritional benefits. In par-
icular, a CIT-enriched diet administered to rats for 3 months
nduces an increase in muscle mass while decreasing fat mass
1,2]. We showed recently that CIT acted directly in white adi-Abbreviations: ASL, argininosuccinate lyase; ASS, argininosuccinate syn-
hase; CD, control diet; CIT, citrulline; HFD, high-fat diet; IL, interleukin;
NFγ , interferon gamma; NOS, nitric oxide synthase; NFκB, nuclear fac-
or κ B; RET, retroperitoneal; TNF-α, tumor necrosis factor alpha; UCP1,
ncoupling protein 1; WAT, white adipose tissue.
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ccess article under the CC BY-NC-ND license (http://creativecommons.org/licensose tissue (WAT) explants from young (2–4 month-old) rats
hether fed a control (CD) or a high-fat (HFD) diet [1,3]. Specif-
cally, CIT induced lipolysis, beta-oxidation and the expression
f uncoupling protein 1 (UCP1), while it reduced glyceroneo-
enesis and fatty acid re-esterification [3,4]. In aged rats (25-
onth-old) CIT was also lipolytic and anti-glyceroneogenic but
id not affect beta-oxidation and UCP1 [1,4]. In addition to its
etabolic effects, CIT also presented anti-inflammatory actions
electively in explants from HFD young rats [3].
Leptin and adiponectin play crucial roles in the regulation of
nflammation [5–7]. Although WAT is heterogeneous, leptin and
diponectine are selectively produced in adipocytes [8,9]. Leptin
s also a pro-inflammatory cytokine that induces the expression
f interferon gamma (INFγ ), tumor necrosis factor alpha (TNF-
), interleukin-1β (IL-1β) and interleukin-6 (IL-6), in immuneFrançaise de Biochimie et Biologie Moléculaire (SFBBM). This is an open
es/by-nc-nd/4.0/).
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fcells such as macrophages, neutrophils and T cells [7,10]. In con-
trast, adiponectin is an important anti-inflammatory adipokine
that inhibits nuclear factor κB (NFκB) and is implicated in the
switch of M1 macrophages towards M2 [11,12]. The secretion
of anti-inflammatory cytokines, including adiponectin, is associ-
ated with a lower level of adiposity, whereas the over expression
of pro-inflammatory cytokines, like leptin, is linked to WAT
mass expansion and frequently associated with insulin resis-
tance, type 2 diabetes and atherosclerosis [9,13–15].
Calorie restriction down-regulates WAT leptin levels in rats
and in obese patients [16–18].
In contrast, plasma adiponectin levels are reduced in obese
rodents and humans while calorie restriction up-regulates its ex-
pression [14,16,18,19]. This hormone exerts protective effects
against the development of diabetes, atherosclerosis or inflam-
mation [20,21].
During aging, an alteration of WAT distribution is also fre-
quently observed in humans and rodents. This redistribution is
commonly characterized by the loss of subcutaneous fat mass,
whereas intra-abdominal fat is augmented [22,23]. As seen in
overweight or obesity, the synthesis and function of leptin and
adiponectin are altered with age, in addition to the common
occurrence of a pro-inflammatory status [1,16]. Aging is also
associated with a status of leptin resistance and/or with a de-
crease in leptin receptors [24,25]. In contrast, blood adiponectin
level declines with age in rats and humans and its rise correlates
with an increase in lifespan and a decrease in the prevalence of
many obesity-related diseases [16,26–28].
The objective of this study was to evaluate the efficacy of CIT
treatment on the expression of leptin, adiponectin and inflamma-
tory marker genes in retroperitoneal (RET) WAT explants from
CD-fed and HFD-fed young rats together with old rats.
2. Materials and methods
2.1. Animals
The protocols for in vivo and ex vivo studies on male Sprague
Dawley rats was conducted as previously described and in agree-
ment with the French Guidelines for the care and use of exper-
imental animals [1–3]. The anthropometric and biological pa-
rameters of each group were described in our previous studies
[1–3].
2.2. Culture of explants
About 200 mg of tissues were cut into fragments of ap-
proximately 20 mg and cultured in Krebs Ringer buffer saline
(KREBS) medium as previously described [1,3]. Explants were
exposed to 2.5 mmol/L CIT for 24 h then frozen before further
studies.
2.3. RNA extraction, cDNA synthesis and real-time RT-PCR
Total RNA was extracted from RET WAT with Rneasy
lipid tissue mini kit from Qiagen. Methods of RNA Ex-
traction, cDNA Synthesis, Real-time RT-PCR and primerequences were identical to those previously described [1,3,4].
equences of the rat sense and antisense nucleotides for leptin
nd adiponectin were: Leptin: 5′-aggtggaggtgaactggarcggg -3′
′
-ggcccacaaagtcctctcagcac3′; Adiponectin: 5′- gcactggcaagttc-
actgcaa 3′ 5′-gtaggtgaagagaacggccttgt-3′.
.4. Statistical analysis
Data are presented as means ± SEM (n = 7). Each indepen-
ent experiment was carried out in triplicate. Statistical analysis
as carried out using the nonparametric Mann & Whitney U test
or pairwise comparisons, which was applied due to the small
umber of experiments (n < 10). A value of P < 0.05 was con-
idered as significant.
∗P < 0.05 vs. control; ∗∗P < 0.01 vs. control.
. Results
.1. In vivo effects of diet and age on the expression of
eptin and adiponectin genes
Overweight or obesity and aging induce changes in body
omposition with a dysregulation of leptin and adiponectine
xpression [9,14]. We evaluated the effect of HFD and aging
n the relative leptin and adiponectin gene expressions in RET
AT. HFD increased leptin gene expression 345% above control
nd decreased adiponectin mRNA 48% in comparison with 4-
onth-old CD animals taken as controls (Fig. 1A). Leptin and
diponectin mRNA levels were similar between 2-month-old
nd 4-month-old CD rats (Fig. 1B). In contrast, leptin mRNA
as up-regulated 275% above control and adiponectin mRNA
as down-regulated 60% in explants from 25-month-old CD
ats (Fig. 1B).
.2. Effects of CIT on the expression of genes coding leptin,
diponectin and inflammatory markers
In RET WAT from old rats that were fed a CIT-supplemented
iet for 3 months, leptin mRNA was down-regulated (62%)
hereas adiponectin mRNA was up-regulated (232% above con-
rol) (Fig. 2A). This CIT-supplementation reduced significantly
he expression of F4/80 (64%) and CD68 (66%) macrophage
arkers together with a decrease in that of inflammatory markers
uch as IL-6 (23%), TNF-α (97%) and NOS II (82%) (Fig. 2A).
n contrast, ASS and ASL mRNA remained unaffected by CIT-
upplementation (Fig. 2A).
In cultured RET WAT explants from 2-month-old and 4-
onth-old rats under either CD or HFD, a 24 h treatment with
.5 mmol/L CIT did not affect leptin gene expression (Fig. 2B).
owever, CIT diminished leptin mRNA 66% selectively in ex-
lants from 25-month-old rats (Fig. 2B). In contrast, adiponectin
ene expression was up-regulated (151%, 362% and 216%) by
IT in RET WAT explants from 4-month-old CD or HFD rats
nd 25-month-old CD rats respectively, while it remained unaf-
ected in explants from 2-month-old CD rats (Fig. 2B).
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Fig. 1. In vivo effects of high-fat-diet feeding (A) and aging (B) on the
expression of leptin and adiponectin genes in RET WAT from rats. RET
WAT explants from 4-month-old CD, 4-month-old HFD and 25-month-old
CD rats were cultured for 24 h as described in materials and methods. Leptin
and adiponectin mRNA levels were evaluated by RT-qPCR. Results were
normalized to RPL13 mRNA and expressed in % of control. Results represent
the mean ± SEM of independent experiments (n = 7) carried out in triplicate
from different explants. ∗P < 0.05 vs. Control; ∗∗P < 0.01 vs. Control.
(A) Effects of diet on leptin and adiponectin gene expressions. Histograms
represent the ratio of the values obtained from 4-month-old HFD rats to
the values obtained from 4-month-old CD rats, taken as controls (100%).
(B) Effects of age on leptin and adiponectin gene expressions. Histograms
represent the ratio of the values obtained from 4-month-old CD or 25-month-
old CD rats to the values obtained from 2-month-old CD rats, taken as
controls (100%).
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(. Discussion
We show that overweight and aging up-regulate leptin gene
xpression and reduce adiponectin gene expression in RET WATig. 2. Effects of CIT in vivo (A) or ex vivo (B) on the expression of leptin, a
ats. (A) Leptin, adiponectin, F4/80 Cd68, Il-6, TNF-α, NOS II, ASS and ASL m
upplemented diet for 3 months were evaluated by RT-qPCR as described in mater
n % of control. Control values (100%) were obtained from 25-month-old CD rats
xperiments (n = 7) carried out in triplicate from different explants. (B) Leptin a
ats, 4-month-old CD rats, 4-month-old HFD rats and 25-month-old CD rats incub
ere evaluated by RT-qPCR as described in materials and methods. Results were
100%) correspond to those obtained in untreated explants from rats of the corresp
n = 7) carried out in triplicate from different explants. ∗P < 0.05 vs. Control; ∗rom rats, in accordance with previous studies using epididymal
AT from rodents [16,19,29]. In addition, the expression of
eptin, macrophage and inflammatory marker genes is down-
egulated while adiponectin mRNA is up-regulated in RET
AT from 25-month-old rats fed a CIT-supplemented diet for
months. We show also that a 24 h treatment of RET WAT ex-
lants from 4-month-old CD or HFD rats and 25-month-old rats
ith 2.5 mmol/L CIT augments adiponectin mRNA. However,
IT diminishes leptin gene expression selectively in explants
rom 25-month-old rats.
Our previous results established that CIT induced direct,
apid and deep modifications of inflammation status and NEFA
etabolism in RET WAT explants from rats, with different
echanisms depending on the status of the animals [1,3]. Lep-
in exerts positive effect on NEFA metabolism, particularly on
-oxidation [30]. In RET WAT from 25-month-old rats, the
ecrease in leptin mRNA could explain why CIT cannot in-
rease β-oxidation while such an increase is observed in 4-
onth-old HFD rats in link with the maintained level of leptin
RNA.
Obesity or overweight, and aging can be considered as similar
ituations when it comes to fat mass, since they share an augmen-
ation of the ratio of fat to lean mass, more specifically in favor
f visceral WAT [26]. In both cases, serum adiponectin level is
ecreased whereas inflammatory markers and leptin level are
ncreased [5–7]. In our study, a CIT-supplemented diet admin-
stered to 25-month-old rats produced a reduction of F4/80 and
D68 mRNA, suggesting a decrease in macrophages in RET
AT. This is consistent with the CIT-induced down-regulation
f IL-6, TNF-α and NOS II mRNA leading to a reversal of the
ro-inflammatory status linked to aging. In previous studies the
xpression of leptin and adiponectin genes have not been always
pproached [5–7]. It can however be assumed that the level of
xpression of adiponectin and leptin genes would reflect the
ariations of protein levels observed in serum [19,29]. In thatdiponectin and inflammatory marker genes in RET WAT explants from
RNA levels in RET WAT explants from 25-month-old CD rats fed the CIT
ials and methods. Results were normalized to RPL13 mRNA and expressed
in the absence of CIT. Results represent the mean ± SEM of independent
nd adiponectin mRNA levels in RET WAT explants from 2-month-old CD
ated without or with 2.5 mmol/L CIT, as indicated, for 24 h. mRNA levels
normalized to RPL13 mRNA and expressed in % of control. Control values
onding age. Results represent the mean ± SEM of independent experiments
∗P < 0.01 vs. Control.
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[
[
[
[
[
[
[
[context, CIT, whether given in vivo as food supplement or
ex vivo on WAT explants, tends to normalize leptin and
adiponectin gene expressions to values similar to those obtained
from young lean rats. It tends also to attenuate inflammation, as
we show here in vivo, in agreement with our previous ex vivo
results [3].
Other in vivo studies showed that natural compound that
can be taken as food supplements can have effects similar to
those of CIT. For instance, arginine-supplemented diet in hu-
mans provokes an increase in plasma adiponectin and an anti-
inflammatory effect [31–33]. A lycopene-supplemented HFD in
young rats reduces leptin mRNA and protein in epididymal WAT
and serum [29]. Like CIT, lycopene possesses anti-inflammatory
and antioxidant properties [2,29,34]. Whether or not the antiox-
idant effect of CIT could be related to its action on WAT remains
an opened question.
A low-grade inflammatory status was reported to be involved
in the development of pathological disorders linked to over-
weight or obesity and to aging [35,36]. These disorders are also
associated with leptin resistance [24,25]. The involvement of
leptinemia and leptin receptors for potential leptin resistance in
the present study remains to be determined. A link between low
adiponectine levels and increased risk for the development of
type 2 diabetes and atherosclerosis was observed in obese hu-
mans, compared to their leaner counterparts, whether adjustment
was made or not with body mass index [21,37]. In our study, the
animals do not develop diabetes neither with aging nor HFD,
as demonstrated by the lack of difference in insulinemia and
glycemia [1,3]. However, CIT treatment could prevent the dele-
terious metabolic effects linked to obesity and aging, that could
develop on a longer-term basis.
5. Conclusion
Our results show that CIT has the capacity to restore lev-
els of expression of adiponectin and leptin genes close to those
found in healthy young rats. These observations, together with
the previously described impact of this amino-acid on WAT
metabolism, reinforce the idea that CIT exerts an important
beneficial action for overweight and aged subjects. This natural
compound could thus represent a new strategy to reduce WAT
mass and the associated inflammation, in relation with obesity
and aging.
Conflicts of interests
No conflict of interest.
Acknowledgements
We thank Dr. Brigitte Potier for providing us with a series of
old rats. We acknowledge the Institut National de la Santé et de
la Recherche Médicale and the Université Paris Descartes for
their financial support.eferences
[1] N. Joffin, A.-M. Jaubert, S. Durant, J. Bastin, J.-P. De Bandt,
L. Cynober, et al., Citrulline induces fatty acid release selectively in
visceral adipose tissue from old rats, Mol. Nutr. Food Res. 58 (2014)
1765–1775. http://dx.doi.org/10.1002/mnfr.201400053.
[2] C. Moinard, S. Le Plénier, P. Noirez, B. Morio, D. Bonnefont-Rousselot,
C. Kharchi, et al., Citrulline supplementation induces changes in body
composition and limits metabolic alterations in healthy aged rats, J.
Nutr. (27 May 2015) pii:jn200626. [Epub ahead of print].
[3] N. Joffin, A.-M. Jaubert, S. Durant, J. Bastin, J.-P. De Bandt,
L. Cynober, et al., Citrulline reduces glyceroneogenesis and induces
fatty acid release in visceral adipose tissue from overweight rats, Mol.
Nutr. Food Res. 58 (2014) 2320–2330. http://dx.doi.org/10.1002/mnfr.
201400507.
[4] N. Joffin, A.-M. Jaubert, J. Bamba, R. Barouki, P. Noirez, C. For-
est, Acute induction of uncoupling protein 1 by citrulline in cultured
explants of white adipose tissue from lean and high-fat-diet-fed rats,
Adipocyte 4 (2015) 129–134. http://dx.doi.org/10.4161/21623945.2014.
989748.
[5] C. Grunfeld, C. Zhao, J. Fuller, A. Pollack, A. Moser, J. Friedman,
et al., Endotoxin and cytokines induce expression of leptin, the ob gene
product, in hamsters, J. Clin. Invest 97 (1996) 2152–2157. http://dx.doi.
org/10.1172/JCI118653.
[6] G. Fantuzzi, Adipose tissue, adipokines, and inflammation, J. Allergy
Clin. Immunol. 115 (2005) 911–919 quiz 920. http://dx.doi.org/10.1016/
j.jaci.2005.02.023.
[7] F. Carbone, C. La Rocca, G. Matarese, Immunological functions of
leptin and adiponectin, Biochimie 94 (2012) 2082–2088. http://dx.doi.
org/10.1016/j.biochi.2012.05.018.
[8] P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, H.F. Lodish, A
novel serum protein similar to C1q, produced exclusively in adipocytes,
J. Biol. Chem. 270 (1995) 26746–26749.
[9] G. Frühbeck, S.A. Jebb, A.M. Prentice, Leptin: physiology and patho-
physiology, Clin. Physiol. Oxf. Engl. 18 (1998) 399–419.
10] Y. Zhao, R. Sun, L. You, C. Gao, Z. Tian, Expression of leptin receptors
and response to leptin stimulation of human natural killer cell lines,
Biochem. Biophys. Res. Commun. 300 (2003) 247–252.
11] N. Ouchi, S. Kihara, Y. Arita, Y. Okamoto, K. Maeda, H. Kuriyama,
et al., Adiponectin, an adipocyte-derived plasma protein, inhibits en-
dothelial NF-kappaB signaling through a cAMP-dependent pathway,
Circulation 102 (2000) 1296–1301.
12] K. Ohashi, J.L. Parker, N. Ouchi, A. Higuchi, J.A. Vita, N. Gokce,
et al., Adiponectin promotes macrophage polarization toward an anti-
inflammatory phenotype, J. Biol. Chem. 285 (2010) 6153–6160. http:
//dx.doi.org/10.1074/jbc.M109.088708.
13] G.S. Hotamisligil, P. Arner, J.F. Caro, R.L. Atkinson, B.M. Spiegelman,
Increased adipose tissue expression of tumor necrosis factor-alpha in
human obesity and insulin resistance, J. Clin. Invest 95 (1995) 2409–
2415. http://dx.doi.org/10.1172/JCI117936.
14] Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa,
et al., Paradoxical decrease of an adipose-specific protein, adiponectin,
in obesity, Biochem. Biophys. Res. Commun. 257 (1999) 79–83.
15] M.G. Myers, M.A. Cowley, H. Münzberg, Mechanisms of leptin action
and leptin resistance, Annu. Rev. Physiol. 70 (2008) 537–556. http:
//dx.doi.org/10.1146/annurev.physiol.70.113006.100707.
16] M. Zhu, G.D. Lee, L. Ding, J. Hu, G. Qiu, R. de Cabo, et al.,
Adipogenic signaling in rat white adipose tissue: modulation by ag-
ing and calorie restriction, Exp. Gerontol. 42 (2007) 733–744. http:
//dx.doi.org/10.1016/j.exger.2007.05.011.
17] D.A. de Luis, R. Aller, O. Izaola, M.G. Sagrado, R. Conde, D. Bellido,
Influence of insulin resistance and adipocytokines on elevated serum
alanine aminotransferase in obese patients, Arch. Med. Res. 39 (2008)
110–114. http://dx.doi.org/10.1016/j.arcmed.2007.06.009.
18] G.V. Bôas Huguenin, S. Kimi Uehara, J.F. Nogueira Netto, E. Gaspar de
Moura, G. Rosa, M.C. da Fonseca Passos, Short term low-calorie diet
improves insulin sensitivity and metabolic parameters in obese women,
N. Joffin et al. /Biochimie Open 1 (2015) 1–5 5
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[Nutr. Hosp. 30 (2014) 53–59. http://dx.doi.org/10.3305/nh.2014.30.1.
7464.
19] T.P. Combs, A.H. Berg, M.W. Rajala, S. Klebanov, P. Iyengar,
J.C. Jimenez-Chillaron, et al., Sexual differentiation, pregnancy, calo-
rie restriction, and aging affect the adipocyte-specific secretory protein
adiponectin, Diabetes 52 (2003) 268–276.
20] M. Okada-Iwabu, T. Yamauchi, M. Iwabu, T. Honma, K. Hamagami,
K. Matsuda, et al., A small-molecule AdipoR agonist for type 2 diabetes
and short life in obesity, Nature 503 (2013) 493–499. http://dx.doi.org/
10.1038/nature12656.
21] S.G. Wannamethee, G.D.O. Lowe, A. Rumley, L. Cherry, P.H. Whincup,
N. Sattar, Adipokines and risk of type 2 diabetes in older men, Diabetes
Care 30 (2007) 1200–1205. http://dx.doi.org/10.2337/dc06-2416.
22] V.A. Hughes, R. Roubenoff, M. Wood, W.R. Frontera, W.J. Evans,
M.A.F. Singh, Anthropometric assessment of 10-y changes in body com-
position in the elderly, Am. J. Clin. Nutr. 80 (2004) 475–482.
23] F. Escrivá, M.L. Gavete, Y. Fermín, C. Pérez, N. Gallardo, C. Alvarez,
et al., Effect of age and moderate food restriction on insulin sensitivity
in Wistar rats: role of adiposity, J. Endocrinol. 194 (2007) 131–141.
http://dx.doi.org/10.1677/joe.1.07043.
24] P.J. Scarpace, M. Matheny, R.L. Moore, N. Tümer, Impaired leptin
responsiveness in aged rats, Diabetes 49 (2000) 431–435.
25] A.S. Ryan, D.M. Berman, B.J. Nicklas, M. Sinha, R.L. Gingerich,
G.S. Meneilly, et al., Plasma adiponectin and leptin levels, body com-
position, and glucose utilization in adult women with wide ranges of
age and obesity, Diabetes Care 26 (2003) 2383–2388.
26] N. Vilarrasa, J. Vendrell, J. Maravall, M. Broch, A. Estepa, A. Megia,
et al., Distribution and determinants of adiponectin, resistin and ghrelin
in a randomly selected healthy population, Clin. Endocrinol. (Oxf.) 63
(2005) 329–335. http://dx.doi.org/10.1111/j.1365-2265.2005.02346.x.
27] Y. Arai, M. Takayama, Y. Abe, N. Hirose, Adipokines and aging, J.
Atheroscler. Thromb. 18 (2011) 545–550.
28] J. McKee Alderman, M.A. DePetrillo, A.M. Gluesenkamp, A.C. Hartley,
S.V. Verhoff, K.L. Zavodni, et al., Calorie restriction and dwarf mice in
gerontological research, Gerontology 56 (2010) 404–409. http://dx.doi.
org/10.1159/000235720.29] R. de A.M. Luvizotto, A.F. Nascimento, E. Imaizumi, D.T. Pierine,
S.J. Conde, C.R. Correa, et al., Lycopene supplementation modulates
plasma concentrations and epididymal adipose tissue mRNA of leptin,
resistin and IL-6 in diet-induced obese rats, Br. J. Nutr. 110 (2013)
1803–1809. http://dx.doi.org/10.1017/S0007114513001256.
30] S. Carter, A. Caron, D. Richard, F. Picard, Role of leptin resistance
in the development of obesity in older patients, Clin. Interv. Aging 8
(2013) 829–844. http://dx.doi.org/10.2147/CIA.S36367.
31] P. Bogdanski, J. Suliburska, K. Grabanska, K. Musialik, A. Cieslewicz,
A. Skoluda, et al., Effect of 3-month L-arginine supplementation
on insulin resistance and tumor necrosis factor activity in patients
with visceral obesity, Eur. Rev. Med. Pharmacol. Sci. 16 (2012) 816–
823.
32] P. Lucotti, E. Setola, L.D. Monti, E. Galluccio, S. Costa, E.P. Sandoli,
et al., Beneficial effects of a long-term oral L-arginine treatment added
to a hypocaloric diet and exercise training program in obese, insulin-
resistant type 2 diabetic patients, Am. J. Physiol. Endocrinol. Metab.
291 (2006) E906–E912. http://dx.doi.org/10.1152/ajpendo.00002.2006.
33] D. De Luis, O. Izaola, B. De la Fuente, R. Aller, Effect of L-arginine
supplmentation on insulin resistance and adipocitokines levels in head
and neck cancer non diabetic patients after surgery, Nutr. Hosp. 30
(2014) 870–875. http://dx.doi.org/10.3305/nh.2014.30.4.7864.
34] K. Akashi, C. Miyake, A. Yokota, Citrulline, a novel compatible so-
lute in drought-tolerant wild watermelon leaves, is an efficient hydroxyl
radical scavenger, FEBS Lett. 508 (2001) 438–442.
35] A. Salminen, J. Huuskonen, J. Ojala, A. Kauppinen, K. Kaarniranta,
T. Suuronen, Activation of innate immunity system during aging: NF-
kB signaling is the molecular culprit of inflamm-aging, Ageing Res.
Rev. 7 (2008) 83–105. http://dx.doi.org/10.1016/j.arr.2007.09.002.
36] G.S. Hotamisligil, N.S. Shargill, B.M. Spiegelman, Adipose expression
of tumor necrosis factor-alpha: direct role in obesity-linked insulin re-
sistance, Science 259 (1993) 87–91.
37] K. Ohashi, N. Ouchi, Y. Matsuzawa, Anti-inflammatory and anti-
atherogenic properties of adiponectin, Biochimie 94 (2012) 2137–2142.
http://dx.doi.org/10.1016/j.biochi.2012.06.008.
